Lewis Bender
Chief Executive Officer at INTENSITY THERAPEUTICS, INC.
Net worth: 8 M $ as of 2024-04-29
Lewis Bender active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Chairman | 2012-03-31 | - |
| Chief Executive Officer | 2012-03-31 | - | |
| Founder | 2011-12-31 | - | |
| Director/Board Member | 2011-12-31 | - | |
| President | 2011-12-31 | - |
Career history of Lewis Bender
Former positions of Lewis Bender
| Companies | Position | Start | End |
|---|---|---|---|
| INTERLEUKIN GENETICS, INC | Director/Board Member | 2011-02-16 | 2012-08-22 |
| Chief Executive Officer | 2008-01-21 | 2012-08-22 | |
| EMISPHERE TECHNOLOGIES, INC. | Chief Executive Officer | 1992-12-31 | 2007-11-30 |
| Chief Tech/Sci/R&D Officer | 1992-12-31 | 2007-11-30 | |
| President | 1992-12-31 | 2007-11-30 |
Training of Lewis Bender
| University of Pennsylvania | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
- Stock Market
- Insiders
- Lewis Bender
- Experience
